课题基金 / 基金详情

Novel Hydrocyanine Probes for the Accurate Detection of Reactive Oxygen Species

Novel Hydrocyanine Probes for the Accurate Detection of Reactive Oxygen Species
用于准确检测活性氧的新型氢氰探针
批准号:
8647969
负责人:
Jon P Anderson
金额:
$21.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2016-01-31

项目摘要

项目成果

Jon P Anderson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):活性氧(ROS)参与许多细胞信号通路。它们与150多种疾病有关,包括癌症、关节炎、帕金森病、糖尿病、心肌梗死和动脉粥样硬化。仅在过去五年中,这一领域就出版了8万份出版物,证明有必要了解民政事务处在这些进程中的作用。最近,在一篇被James D. Watson称为“自双螺旋结构以来我最重要的工作之一”的论文中,他提出了一种理论,将癌症晚期的进展与抗氧化剂的存在和ROS的作用联系起来(Watson, J. Open Biol. 2013,3,120144)。尽管对活性氧的研究有着巨大的兴趣和重要性,但目前还没有一种探针能够结合可靠性、灵敏度和效率来检测细胞培养、离体和体内的活性氧。目前市面上还没有能在体内成像ROS的探针,这对理解ROS在其原生环境中的作用构成了重大障碍(7)。此外,目前还没有一种探针可以在细胞培养或体内对ROS进行定量成像。最近,一类新的ROS探针——氢花菁被开发出来,它们有望极大地推进ROS在体外、离体和体内的研究。本提案的主要研究者是氢菁探针的最初共同发明者。为了对细胞过程和疾病生物学进行前所未有的研究,我们建议开发一个商业荧光氢菁探针家族,它可以准确地检测活细胞、组织样本、血液中低纳摩尔浓度的ROS,并首次在整个动物中检测。本项目的目的是开发新的策略,使氢氰胺成为高度准确和强大的ROS探针,用于体外和体内研究应用。由于比例氢花菁探针的发展,ROS的定量成像也首次成为可能。该项目的具体目标是:特异性目标1:开发低背景荧光的新型水溶性氢菁菁特异性目标2:在细胞培养中验证新型氢菁菁特异性目标3:开发用于定量ROS成像的比例氢菁菁探针特异性目标4:这个一期SBIR项目的成功完成将建立低本底氢菁的商业可行性,并使LI-COR能够为生物医学研究人员提供一个强大、简单和通用的工具箱来研究任何生物样品中的活性氧。在第二阶段,氢氰胺探针将用于工业药物筛选和潜在的临床诊断应用。用于体内ROS定量成像的比例氢花青素也将在II期开发。我们认为该提案非常适合题为“从实验室到市场:生物医学和行为研究工具(SBIR [R43/R44])”的资助机会。
英文摘要
DESCRIPTION (provided by applicant): Reactive oxygen species (ROS) are involved in numerous cell-signaling pathways. They have been implicated in over 150 diseases including cancer, arthritis, Parkinson's disease, diabetes, myocardial infarction and atherosclerosis. The need to understand the role of ROS in these processes is evidenced by the 80,000 publications in this field during the last five years alone. Recently, in a paper James D. Watson called "among my most important work since the double helix,", he posited a theory that links cancer progression in late stages of the disease to the presence of antioxidants and the role of ROS (Watson, J. Open Biol. 2013, 3, 120144). Despite the immense interest and importance of ROS research, there are no probes that combine reliability, sensitivity, and efficiency for detecting ROS in cell culture, ex vivo, and in vivo. No current commercially available probe can image ROS in vivo, which presents a significant impediment in understanding the role of ROS in their native environment (7). Furthermore, there is no probe which can quantitatively image ROS in cell culture or in vivo. A new class of ROS probes, hydrocyanines, has recently been developed and they hold promise of greatly advancing the study of ROS in vitro, ex vivo and in vivo. The principal investigator of this proposal is the original co-inventor of hydrocyanine probes. In orde to enable unprecedented investigations of cellular processes and disease biology, we propose to develop a commercial family of fluorescent hydrocyanine probes, which accurately detects ROS at low nanomolar concentrations in living cells, tissue samples, blood, and for the first time in whole animals. The objective of this project is to develop novel strategies for the hydrocyanines to establish them as highly accurate and robust ROS probes for in vitro and in vivo research applications. For the first time, quantitative imaging of ROS would also be enabled by the development of ratiometric hydrocyanines probes. The specific aims of this project are: Specific Aim I: Develop novel water-soluble hydrocyanines with low background fluorescence Specific Aim II: Validate the novel hydrocyanines in cell-culture Specific Aim III: Develop ratiometric hydrocyanine probes for quantitative ROS imaging Specific Aim IV: Validate ratiometric hydrocyanines in cell-culture The successful completion of this Phase I SBIR project will establish the commercial feasibility of the low background hydrocyanines, and enable LI-COR to provide biomedical researchers with a robust, simple and versatile toolbox to study ROS in any biological sample. In Phase II, hydrocyanine probes will be developed for industrial drug screening and potential clinical diagnostic applications. Ratiometric hydrocyanines for quantitative in vivo imaging of ROS will also be developed in Phase II. We believe that this proposal is ideally suited for the funding opportunity titled "Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44])".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Silica Colloidal Crystals for High Resolution MALDI-MS of Glycoproteins
  • 批准号:
    8781037
  • 项目类别:
  • 资助金额:
    $30.65万
  • 财政年份:
    2014
  • 负责人:
    Jon P Anderson
  • 依托单位:
Silica Colloidal Crystals for High Resolution MALDI-MS of Glycoproteins
  • 批准号:
    8927044
  • 项目类别:
  • 资助金额:
    $30.65万
  • 财政年份:
    2014
  • 负责人:
    Jon P Anderson
  • 依托单位:
Metal Enhancement for Near-IR Fluorescence Based Membrane Assays
  • 批准号:
    7325405
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2007
  • 负责人:
    Jon P Anderson
  • 依托单位:
Metal Enhancement for a Near-IR Fluorescence Scanner
  • 批准号:
    6932939
  • 项目类别:
  • 资助金额:
    $20.04万
  • 财政年份:
    2005
  • 负责人:
    Jon P Anderson
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究